rs768834663
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_000166.6(GJB1):c.83T>A(p.Ile28Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000166.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.83T>A | p.Ile28Asn | missense_variant | Exon 2 of 2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.83T>A | p.Ile28Asn | missense_variant | Exon 2 of 2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.83T>A | p.Ile28Asn | missense_variant | Exon 2 of 2 | XP_011529209.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183311Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67757
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
- -
- -
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
This sequence change replaces isoleucine, which is neutral and non-polar, with asparagine, which is neutral and polar, at codon 28 of the GJB1 protein (p.Ile28Asn). This variant is present in population databases (rs768834663, gnomAD 0.001%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individuals with Charcot-Marie-Tooth disease type 1X (PMID: 9361298; Invitae). ClinVar contains an entry for this variant (Variation ID: 215983). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GJB1 protein function with a negative predictive value of 80%. This missense change is located in a region of the GJB1 protein in which a significant number of missense variants have been reported (PMID: 21309765). These observations suggest that this may be a clinically significant region of the protein. For these reasons, this variant has been classified as Pathogenic. -
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:1
The GJB1 p.Ile28Asn variant (rs768834663) was reported in a cohort of patients with CMT from Athena diagnostics (Bone, 1997). Among the 130 variants reported in this cohort, several affecting the same codon (c.83T>C; p.Ile28T) or nearby residues (p.Ser26Leu, p.Val27Ala and p.Ile30Asn) were observed in affected patients. This variant is listed in the Genome Aggregation Database (gnomAD) with an overall population frequency of 0.0005 percent (identified on 1 out of 183,311 chromosomes), and reported to ClinVar as a pathogenic variant (Variation ID: 215983). The isoleucine at position 28 is highly conserved across the vertebrates and located in a transmembrane domain. Computational analyses of the p.Ile28Asn variant on protein structure and function indicates a deleterious effect (SIFT: damaging, PolyPhen-2: probably damaging). Based on these observations, the p.Ile28Asn variant is likely to be pathogenic. References: Bone et al. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol Dis. 1997;4(3-4):221-30. -
Inborn genetic diseases Uncertain:1
The p.I28N variant (also known as c.83T>A), located in coding exon 1 of the GJB1 gene, results from a T to A substitution at nucleotide position 83. The isoleucine at codon 28 is replaced by asparagine, an amino acid with dissimilar properties. This alteration was detected in a cohort of patients with Charcot–Marie–Tooth disease (Bone LJ et al. Neurobiol. Dis., 1997;4:221-30). Based on data from gnomAD, the A allele has an overall frequency of 0.0005% (1/183,311) total alleles studied, with 1 hemizygote observed. The highest observed frequency was 0.001% (1/81,818) of European (non-Finnish) alleles. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at